Brooke Aymes is a Oaklyn, New Jersey based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. Her current practice location is 1 E Lakeview Ave, Oaklyn. Patients can book an appointment with her at 856-981-6124.
Brooke Aymes is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Brooke Aymes speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Brooke Aymes
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Female
Credentials:
LSW, LCADC
Accepts Medicare Assignment:
No
Practice Address:
1 E Lakeview Ave, Oaklyn, New Jersey, 08107-1346
Phone:
856-981-6124
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1306457866
NPI Enumeration Date:
10 Aug, 2020
NPI Last Update On:
10 Aug, 2020
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 E Lakeview Ave, Oaklyn, New Jersey
Zip:
08107-1346
Patients can reach Brooke Aymes at 1 E Lakeview Ave, Oaklyn, New Jersey or can call to book an appointment on 856-981-6124. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.